Sugi Predict

Sugi Predict / Compounds / SCHEMBL8692015

SCHEMBL8692015

SCHEMBL8692015

Cc1ccc2c(c1C)CC(N)C2

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 2/20 0.41
▸ FYN P06241 1/20 0.35
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA12 O43570 2/20 0.35
▸ CA7 P43166 2/20 0.35
▸ CA14 Q9ULX7 2/20 0.35
▸ DRD2 P14416 4/20 0.35
▸ DRD3 P35462 4/20 0.35
▸ HTR2A P28223 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ HTR2B P41595 2/20 0.33
▸ PLAU P00749 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29604441 1.00 ADRA1A (0.41) ADRA1AFYNCA1CA2CA12
SCHEMBL20012402 0.80 ADRA1A (0.38) ADRA1AFYNCA1CA2CA12
SCHEMBL24095373 0.80 ADRA1A (0.38) ADRA1AFYNCA1CA2CA12
SCHEMBL29605223 0.79 ADRA1A (0.52) ADRA1AFYNPLAU
SCHEMBL8689448 0.79 ADRA1A (0.52) ADRA1AFYNPLAU
Hydrochloric Acid SCHEMBL25243090 0.79 ADRA1A (0.37) ADRA1AFYNCA1CA2CA12
SCHEMBL410138 0.77 HTR2C (0.37) HTR2AHTR2CHTR2B
SCHEMBL31278528 0.75 DRD2 (0.46) ADRA1AFYNDRD2DRD3PLAU
SCHEMBL2079549 0.75 DRD2 (0.46) ADRA1AFYNDRD2DRD3PLAU
SCHEMBL10881441 0.68 DRD2 (0.56) ADRA1ADRD2DRD3PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112500301-B Regulator for longitudinal behavior 以西结·戈兰 2024-02-13 — — CN claimed
US-20250288541-A1 BINGE BEHAVIOR REGULATORS CLEARMIND LABS CORP. (CA) 2025-09-18 — — US disclosed
US-12357590-B2 Binge behavior regulators Clearmind Medicine Inc. (CA) 2025-07-15 — — US disclosed
US-12350242-B2 Binge behavior regulators Clearmind Medicine Inc. (CA) 2025-07-08 — — US disclosed
US-12064402-B2 Binge behavior regulators Clearmind Medicine Inc. (CA) 2024-08-20 — — US disclosed
WO-2024062395-A1 USE OF 5-METHOXY-2-AMINOINDAN (\"MEAI\") IN METHODS FOR TREATING METABOLIC SYNDROME Clearmind Medicine Inc. (IL) 2024-03-28 — — WO disclosed
CN-112500301-B Regulator for longitudinal behavior 以西结·戈兰 2024-02-13 — — CN disclosed
US-20230092839-A1 ALCOHOLIC BEVERAGE SUBSTITUTES Clearmind Medicine Inc. (CA) 2023-03-23 — — US disclosed
US-11528924-B2 Alcoholic beverage substitutes Clearmind Medicine, Inc. (CA) 2022-12-20 — — US disclosed
CN-114903134-A Alcoholic beverage substitute 以西结·戈兰 2022-08-16 — — CN disclosed
US-10406123-B2 Binge behavior regulators CLEARMIND LABS CORP. (CA) 2019-09-10 — — US disclosed
US-20190054042-A1 BINGE BEHAVIOR REGULATORS CLEARMIND LABS CORP. (CA) 2019-02-21 — — US disclosed
US-10137096-B2 Binge behavior regulators CLEARMIND LABS CORP. (CA) 2018-11-27 — — US disclosed
US-20180085326-A1 BINGE BEHAVIOR REGULATORS CLEARMIND LABS CORP. (CA) 2018-03-29 — — US disclosed
US-20170360067-A1 ALCOHOLIC BEVERAGE SUBSTITUTES CLEARMIND LABS CORP. (CA) 2017-12-21 — — US disclosed
EP-3230256-A1 ALCOHOLIC BEVERAGE SUBSTITUTES Golan, Ezekiel (CA) 2017-10-18 — — EP disclosed
WO-2016092547-A1 ALCOHOLIC BEVERAGE SUBSTITUTES GOLAN EZEKIEL (IL) 2016-06-16 — — WO disclosed
US-5708018-A 2-aminoindans as selective dopamine D3 ligands PHARMACIA & UPJOHN COMPANY (US) 1998-01-13 — — US disclosed
EP-0712387-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1996-05-22 — — EP disclosed
WO-1995004713-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS THE UPJOHN COMPANY (US) 1995-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250288541-A1 BINGE BEHAVIOR REGULATORS GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885
US-20180085326-A1 BINGE BEHAVIOR REGULATORS GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885
US-20230092839-A1 ALCOHOLIC BEVERAGE SUBSTITUTES ADH1A, ADH5, ADH1C ADRA1A 1477/4885FYN 3559/4885CA1 1091/4885
US-12350242-B2 Binge behavior regulators GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885
US-10137096-B2 Binge behavior regulators GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885
US-12064402-B2 Binge behavior regulators GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885
US-20190054042-A1 BINGE BEHAVIOR REGULATORS GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885
US-11528924-B2 Alcoholic beverage substitutes ADH1A, ADH5, ADH1C ADRA1A 1477/4885FYN 3559/4885CA1 1091/4885
US-10406123-B2 Binge behavior regulators GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885
US-12357590-B2 Binge behavior regulators GABRB3, GABRB2, GABRB1 ADRA1A 1345/4885FYN 4855/4885CA1 2927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.